TCT Video: Sharifi aims to TORPEDO DVT via PEVI

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon
Click to play
TCT Video: TORPEDO Principal Investigator Mohsen Sharifi, MD

WASHINGTON, D.C.–Principal Investigator Mohsen Sharifi, MD, of the Arizona Cardiovascular Consultants and Vein clinic and professor at A.T. Still University in Mesa, Ariz., reviews the results of the TORPEDO (Thombus Obliteration by Rapid Percutaneous Endovenous Intervention in Deep Venous Occlusion) trial, the first of its kind to compare percutaneous endovenous intervention (PEVI) techniques to anticoagulation therapy alone in acute symptomatic proximal deep vein thrombosis (DVT) patients.

The results, presented as a late-breaking clinical trial at the 2010 Transcatheter Cardiovascular Therapeutics (TCT) conference this morning, showed that PEVI in combination with anticoagulation therapy may trump treatment with anticoagulation alone.